menu search

Pharmaceuticals stocks, etfs could have power beyond 2022

Pharmaceuticals stocks and the related exchange traded funds are benefiting from the now-steady revenue stream provided by coronavirus v...

February 4, 2022, 11:09 am

Pharmaceuticals stocks, etfs could have power beyond 2022

Pharmaceuticals stocks and the related exchange traded funds are benefiting from the now-steady revenue stream provided by coronavirus v...

February 4, 2022, 11:09 am

Valneva - pfizer choose three-dose schedule for lyme vaccine candidate moving forward

Valneva SE VALN and Pfizer Inc PFE have reported further Phase 2 data for their Lyme disease vaccin...

February 4, 2022, 8:54 am

Valneva - pfizer choose three-dose schedule for lyme vaccine candidate moving forward

Valneva SE VALN and Pfizer Inc PFE have reported further Phase 2 data for their Lyme disease vaccin...

February 4, 2022, 8:54 am

Valneva - pfizer choose three-dose schedule for lyme vaccine candidate moving forward

Valneva SE VALN and Pfizer Inc PFE have reported further Phase 2 data for their Lyme disease vaccin...

February 4, 2022, 8:54 am

Novavax can still succeed, but it's facing high risks

Novavax's vaccine revenues haven't soared yet. But if the FDA approves the shot, the odds could change ...

February 3, 2022, 8:34 am

Novavax can still succeed, but it's facing high risks

Novavax's vaccine revenues haven't soared yet. But if the FDA approves the shot, the odds could change ...

February 3, 2022, 8:34 am

Novavax can still succeed, but it's facing high risks

Novavax's vaccine revenues haven't soared yet. But if the FDA approves the shot, the odds could change ...

February 3, 2022, 8:34 am

U.k. authorizes novavax's covid-19 shot

Shares of Novavax Inc. NVAX, -6.03% gained 0.9% in premarket trading on Thursday after the company said its COVID-19 v...

February 3, 2022, 8:33 am

U.k. authorizes novavax's covid-19 shot

Shares of Novavax Inc. NVAX, -6.03% gained 0.9% in premarket trading on Thursday after the company said its COVID-19 v...

February 3, 2022, 8:33 am

U.k. authorizes novavax's covid-19 shot

Shares of Novavax Inc. NVAX, -6.03% gained 0.9% in premarket trading on Thursday after the company said its COVID-19 v...

February 3, 2022, 8:33 am

Novavax files for u.s. authorization. is the stock finally a buy?

Covid-19 vaccine developer Novavax's stock indicated on Monday that it had finally officially filed for...

February 3, 2022, 7:30 am

Novavax files for u.s. authorization. is the stock finally a buy?

Covid-19 vaccine developer Novavax's stock indicated on Monday that it had finally officially filed for...

February 3, 2022, 7:30 am

Novavax files for u.s. authorization. is the stock finally a buy?

Covid-19 vaccine developer Novavax's stock indicated on Monday that it had finally officially filed for...

February 3, 2022, 7:30 am

Why biden has eased up on facebook over covid misinformation

When U.S. President Joe Biden accused Facebook of "killing people" by spreading vaccine lies in July, m...

February 3, 2022, 6:14 am

Why biden has eased up on facebook over covid misinformation

When U.S. President Joe Biden accused Facebook of "killing people" by spreading vaccine lies in July, m...

February 3, 2022, 6:14 am

Why biden has eased up on facebook over covid misinformation

When U.S. President Joe Biden accused Facebook of "killing people" by spreading vaccine lies in July, m...

February 3, 2022, 6:14 am

Mckesson q3 earnings beat street view, raises fy22 outlook boosted by covid-19 vaccine demand

McKesson Corp MCK reported third-quarter FY22 adjusted EPS of $6.15, +34% Y/Y, and easily beating the analyst consensus of $5.42. Thousands of new t...

February 3, 2022, 5:50 am

Mckesson q3 earnings beat street view, raises fy22 outlook boosted by covid-19 vaccine demand

McKesson Corp MCK reported third-quarter FY22 adjusted EPS of $6.15, +34% Y/Y, and easily beating the analyst consensus of $5.42. Thousands of new t...

February 3, 2022, 5:50 am

Mckesson q3 earnings beat street view, raises fy22 outlook boosted by covid-19 vaccine demand

McKesson Corp MCK reported third-quarter FY22 adjusted EPS of $6.15, +34% Y/Y, and easily beating the analyst consensus of $5.42. Thousands of new t...

February 3, 2022, 5:50 am


Search within

Pages Search Results: